Simplex Trading
VTGN icon

Simplex Trading’s VistaGen Therapeutics VTGN Stock Holding History

Simplex Trading’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7K Buy
56,400
+47,500
+534% +$28.7K ﹤0.01% 7494
2026
Q1 		$5.09K Sell
8,900
-169,800
-95% -$103K ﹤0.01% 7885
2025
Q4 		$118K Buy
178,700
+131,200
+276% +$474K ﹤0.01% 4820
2025
Q3 		$168K Buy
+47,500
New +$142K ﹤0.01% 5148
2025
Q1 		– Sell
-3,500
Closed -$10K – 9800
2024
Q4 		$10K Sell
3,500
-34,500
-91% -$97.1K ﹤0.01% 7223
2024
Q3 		$114K Sell
38,000
-31,300
-45% -$107K ﹤0.01% 5102
2024
Q2 		$241K Sell
69,300
-34,000
-33% -$147K ﹤0.01% 4479
2024
Q1 		$545K Buy
103,300
+98,900
+2,248% +$476K ﹤0.01% 3772
2023
Q4 		$22K Sell
4,400
-4,100
-48% -$15.5K ﹤0.01% 6859
2023
Q3 		$44K Buy
+8,500
New +$37.7K ﹤0.01% 5931
2023
Q1 		– Sell
-460
Closed -$1K – 10238
2022
Q4 		$1K Sell
460
-1,467
-76% -$5.52K ﹤0.01% 8953
2022
Q3 		$8K Buy
1,927
+977
+103% +$9.68K ﹤0.01% 8454
2022
Q2 		$25K Buy
950
+217
+30% +$7.66K ﹤0.01% 7358
2022
Q1 		$27K Sell
733
-144
-16% -$6.28K ﹤0.01% 7912
2021
Q4 		$51K Buy
+877
New +$57.1K ﹤0.01% 7241

Other funds holding VTGN

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Simplex Trading's VTGN Position: Q2 2026 in Review

Simplex Trading reduced its VistaGen Therapeutics (VTGN) stake by 84% in Q2 2026, selling an estimated $45.5K and leaving 14,295 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #8411.

Simplex Trading first reported a position in VTGN in Q2 2022 and has held it in 14 quarters since. The position peaked at $69K in Q3 2024. 49 funds tracked by Wall St. Rank hold VTGN as of Q2 2026.

  • Simplex Trading held 14,295 shares of VistaGen Therapeutics worth $3.23K as of Q2 2026.
  • Simplex Trading sold 75,354 VistaGen Therapeutics shares in Q2 2026, an estimated $45.5K.
  • VistaGen Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8411 holding.
  • Simplex Trading first reported a position in VistaGen Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Simplex Trading's VistaGen Therapeutics position peaked at $69K in Q3 2024.
  • 49 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.